| Class | Num Shares | Value | Price $ | Report Date | Ownership | Underlying Class | Underlying Amount |
|---|---|---|---|---|---|---|---|
| Common Stock | 1,694,388 | $8.83 M | $5.21 | Aug 2, 2021 | F-Prime Capital Partners Life Sciences Fund VI LP | ||
| Series B Preferred Units | 0 | Aug 2, 2021 | F-Prime Capital Partners Life Sciences Fund VI LP | Common Stock |
| Sym | Class | Transaction | % | Value $ | Price $ | Shares | Shares After | Date | Ownership |
|---|